Literature DB >> 21847674

Engineered mammalian vector to express EGFP-tagged proteins as biomarkers.

Geraldo Santana Magalhães1, Juliana Branco Novo, Patricia Bianca Clissa, Maisa Splendore Della Casa, Diego Butera, Ana Maria Moura da Silva.   

Abstract

Due to its specialized post-translational machinery, mammalian cells represent an interesting and not fully explored system to express snake toxins. Therefore, in this work, we built up a new mammalian expression vector that enhances the feasibility to use mammalian cells to express proteins as biomarkers. Among the modifications, an Igκ signal peptide and a 6xHis tag were inserted into this vector in order to drive the protein to the supernatant and simplify its purification, respectively. In addition, to facilitate selection of high producing clones and also tag proteins which may function as a biomarker, the sequence of enhanced green fluorescent protein (EGFP) was added. The efficiency of the resulting vector (pToxEGFP) was tested by cloning and expressing the viper venom disintegrin echistatin (Ech) that due to its affinity to integrin αvβ3 was tested as a molecular marker. Expression of EGFP-Ech was achieved in CHO-DXB11 cells resulting in a yield of 22 mg/L. The binding activity of this chimera protein was successfully achieved on human umbilical vein endothelial cells which highly express αvβ3. The results indicate that pToxEGFP may constitute an efficient and versatile expression vector to express tagged proteins with potential biomarker activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21847674     DOI: 10.1007/s12033-011-9444-0

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  42 in total

1.  The enhanced green fluorescent protein as a tool for the analysis of protein dynamics and localization: local fluorescence study at the single-molecule level.

Authors:  R A Cinelli; A Ferrari; V Pellegrini; M Tyagi; M Giacca; F Beltram
Journal:  Photochem Photobiol       Date:  2000-06       Impact factor: 3.421

2.  Venom-sweet-venom: N-linked glycosylation in snake venom toxins.

Authors:  Sandro G Soares; Leandro L Oliveira
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

3.  Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus.

Authors:  Z R Gan; R J Gould; J W Jacobs; P A Friedman; M A Polokoff
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

Review 4.  Practical applications of snake venom toxins in haemostasis.

Authors:  Neville Marsh; Vaughan Williams
Journal:  Toxicon       Date:  2005-04-07       Impact factor: 3.033

5.  Efficient characterisation of human cell-bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells.

Authors:  Zhidao Xia; Hua Ye; Rachel M Locklin; David J P Ferguson; Zhanfeng Cui; James T Triffitt
Journal:  Biomaterials       Date:  2005-10       Impact factor: 12.479

6.  Characterization of the catalytic residues of the tobacco etch virus 49-kDa proteinase.

Authors:  W G Dougherty; T D Parks; S M Cary; J F Bazan; R J Fletterick
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

7.  Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Cloning, expression, and structural analysis of recombinant BJcuL, a c-type lectin from the Bothrops jararacussu snake venom.

Authors:  Bayki H Kassab; Daniela D de Carvalho; Marcos A Oliveira; Gandhi R Baptista; Gonçalo A G Pereira; José C Novello
Journal:  Protein Expr Purif       Date:  2004-06       Impact factor: 1.650

9.  Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins.

Authors:  Howard Leong-Poi; Jonathan Christiansen; Alexander L Klibanov; Sanjiv Kaul; Jonathan R Lindner
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

View more
  1 in total

Review 1.  Recombinant and Chimeric Disintegrins in Preclinical Research.

Authors:  Victor David; Barbara Barbosa Succar; João Alfredo de Moraes; Roberta Ferreira Gomes Saldanha-Gama; Christina Barja-Fidalgo; Russolina Benedeta Zingali
Journal:  Toxins (Basel)       Date:  2018-08-07       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.